Liquidia Corporation has grown revenue 194% a year over three years and 129% a year over five. Revenue growth, 3-year annual rate: +194% (Drug Manufacturers - Specialty & Generic median +13%). Revenue growth, 5-year rate: +129%, growth has picked up over the last three years. Years of annual history on file: 7, FY2019 to FY2025, as filed.

LQDALiquidia Corporation

Healthcare

$27.39+15% 1Y

$27.39

$21.8052 weeks$91.06

Is it growing?

Mixed

Neither accelerating nor breaking down: revenue growing +2234% year on year and operating margin widening (+893.7 points), but earnings down −178% year on year.

2 good, 1 to watch

Revenue trend+2234% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +129% a year.

Earnings trend−178% in a year

Trailing-twelve-month earnings per share against a year earlier. Growing slower than revenue, so the growth is costing something.

Margin direction+893.7 points operating

Trailing-twelve-month operating margin, 30.2% now against -863.5% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

Revenue growth, 3 yearstop 1% of the market

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is LQDA growing?

Liquidia Corporation has grown revenue 194% a year over three years and 129% a year over five.

+194%

Revenue growth, 3-year annual rate · Drug Manufacturers - Specialty & Generic median +13% · compounding fast · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +129%
Revenue growth, 5-year rate · +194% over three · growth has picked up over the last three years
Years of annual history on file: 7
Years of annual history on file · FY2019 to FY2025, as filed

Details›